Pivotal Importance of STAT3 in Protecting the Heart from Acute and Chronic Stress: New Advancement and Unresolved Issues
Open Access
- 30 November 2015
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 2, 36
Abstract
The transcription factor Signal Transducer and Activator of Transcription 3 (STAT3) has been implicated in protecting the heart from acute ischemic injury under both basal conditions and as a crucial component of pre- and post-conditioning protocols. A number of anti-oxidant and antiapoptotic genes are upregulated by STAT3 via canonical means involving phosphorylation on Y705 and S727, although other incompletely defined posttranslational modifications are involved. In addition, STAT3 is now known to be present in cardiac mitochondria and to exert actions that regulate the electron transport chain, reactive oxygen species (ROS) production, and mitochondrial permeability transition pore (mPTP) opening. These non-canonical actions of STAT3 are enhanced by S727 phosphorylation. The molecular basis for the mitochondrial actions of STAT3 are poorly understood, but STAT3 is known to interact with a critical subunit of complex I and to regulate complex I function. Dysfunctional complex I has been implicated in ischemic injury, heart failure, and the aging process. Evidence also indicates that STAT3 is protective to the heart under chronic stress conditions, including hypertension, pregnancy, and advanced age. Paradoxically, the accumulation of unphosphorylated STAT3 (U-STAT3) in the nucleus has been suggested to drive pathological cardiac hypertrophy and inflammation via noncanonical gene expression, perhaps involving a distinct acetylation profile. U-STAT3 may also regulate chromatin stability. Our understanding of how the noncanonical genomic and mitochondrial actions of STAT3 in the heart are regulated and coordinated with the canonical actions of STAT3 is rudimentary. Here we present an overview of what is currently known about the pleotropic actions of STAT3 in the heart in order to highlight controversies and unresolved issues.Keywords
Funding Information
- American University of Beirut (100410)
- U.S. Department of Veterans Affairs (1IO1BX001355-0A1)
- Université Libanaise
- American Heart Association
- University of Mississippi
This publication has 170 references indexed in Scilit:
- Cytoprotection by the modulation of mitochondrial electron transport chain: The emerging role of mitochondrial STAT3Mitochondrion, 2012
- Mitochondrial Complex I Plays an Essential Role in Human Respirasome AssemblyCell Metabolism, 2012
- Lysine methylation of promoter-bound transcription factors and relevance to cancerCell Research, 2010
- Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusionBasic Research in Cardiology, 2010
- Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in TumorsCancer Cell, 2009
- STAT3 inhibition of gluconeogenesis is downregulated by SirT1Nature Cell Biology, 2009
- A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasisProceedings of the National Academy of Sciences, 2008
- Signal transducer and activator of transcription 3 is involved in the cardioprotective signalling pathway activated by insulin therapy at reperfusionBasic Research in Cardiology, 2008
- Drosophila STAT is required for directly maintaining HP1 localization and heterochromatin stabilityNature Cell Biology, 2008
- Stat3 activation of NF-κB p100 processing involves CBP/p300-mediated acetylationProceedings of the National Academy of Sciences, 2006